A specific oxidoreductase, previously known as apoptosis-inducing-factor mitochondrial-2 (AIFM2), capable of recycling reduced ubiquinol (Co-enzymeQ 10 H 2 ) from ubiquinone at the expense of NAD(P)H, has been presented as a potential ferroptosis inhibitor due to the fact that its overexpression complements the loss of GPx4 in PFA1 and human fibrosarcoma (66, 67)
It sits in the extracellular matrix and, upon injury or mechanical stress, binds to c-met receptors on muscle satellite cells, activating them from quiescence so they can multiply and rebuild muscle fibers
Fatigue, weakness, lightheadedness, and dizziness are common symptoms of anemia
Glutathione is a natural antioxidant that your body produces on its own
The identification of oxygen as the ultimate electron acceptor after the formation of disulphide bonds in proteins means that the products of the reduction of oxygen have to be removed to prevent damage to cellular components
FIGURE 4 While spin traps and nitroxides may possess significant therapeutic potential, their clinical applications may be limited by poor bioavailability and targeting and inadequate BBB penetration (mainly due to low lipophilicity)